European Archives - Page 1109 of 1327 - European Medical Journal

Introducing EMJ Allergy & Immunology 2.1

United Kingdom, August 03, 2017: EMJ would like to welcome you to the latest edition of EMJ Allergy and Immunology. This much-anticipated eJournal…

EMJ Allergy & Immunology 2.1 2017

EMJ would like to welcome you to the latest edition of EMJ Allergy and Immunology. This much-anticipated eJournal contains a comprehensive summary…

Review of the 61st European Academy of Allergy and Clinical Immunology Congress 2017

The largest allergy congress in the world was this year hosted in the scenic city of Helsinki, Finland.

Rapid Desensitisation for the Management of Hypersensitivity Reaction to Biologicals: Infliximab and Adalimumab in Inflammatory Bowel Disease Patients

Biologicals in the treatment of inflammatory bowel disease are important, but their usefulness is limited in patients with hypersensitivity reaction.

Hypersensitivity to Natural Rubber Latex gloves among Albanian Dental Students

Latex allergy is a common occupational disease among healthcare workers who use latex gloves. Read more about it

Skin Prick Reactivity to 80 Different Allergens Among 144 Medical Students in Birjand, Iran

Allergic disorders are among the most prevalent health problems around the world, particularly in low and middle-income countries.

Future of the Allergists and Allergen Specific Immunotherapy (FASIT) Meets EACCI

The FASIT meetings ensure conversations do not remain as just academic discussions in ivory towers, but are shared widely throughout the world

Controversies on Special Products for Managing Cow’s Milk Protein Allergy in Infants: Safety and Suitability

A Task Force was established with the objective of addressing the need for improved knowledge regarding treatment of infants with CMPA.

Ragweed Pollen Allergy: Patterns and Cross-Reactivity

The aim of this study was to determine the impact of ragweed pollen on allergic patients from western Romania.

Pollen Allergy Potency for the Main Urban Plants

Pollinosis, or respiratory allergy due to pollen grains, is a real pathology for 20–30% of the European population.